Fig. 2 | Cellular & Molecular Immunology

Fig. 2

From: PANoptosis in cancer: bridging molecular mechanisms to therapeutic innovations

Fig. 2The alternative text for this image may have been generated using AI.

The interplay of PANoptosis between cancer cells and TIME. On the one hand, PANoptotic tumor cells release inflammatory factors or DAMPs, which enhance DCs maturation, M2-to-M1 macrophage repolarization, CD4+/CD8+ T cell infiltration and activate NK cells, while deplete Tregs to orchestrate immune activation and subsequently suppress tumor development. On the other hand, macrophages are induced to PANoptosis via TNF-α + IFN-γ—JAK/STAT1—IRF1—RIPK1/caspase-8 axis, IFNs+NEIs—ADAR1—ZBP1 axis, or baicalin—mitochondrial injury—ZBP1 axis to enhance inflammatory responses and immune activation (CBL0137 is the agonist of ZBP1), while neutrophils are induced to PANoptosis via diABZI—STING—AIM2/NLRP3 axis and the interaction of GATA2—HMGB1—TIM-3 axis with DCs to inhibit immune activation

Back to article page